Safety and efficacy of combination therapy with pegylated interferon alpha-2a and ribavirin in treating patients with chronic hepatitis C and beta-thalassaemia major: a Greek single-center experience.

Acta Haematol

Second Medical Department, Aristotle University, Thessaloniki, Greece.

Published: January 2012

Download full-text PDF	Source
http://dx.doi.org/10.1159/000330516	DOI Listing

Publication Analysis

safety efficacy

efficacy combination

combination therapy

therapy pegylated

pegylated interferon

interferon alpha-2a

alpha-2a ribavirin

ribavirin treating

treating patients

patients chronic

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!